ATRA
Atara Biotherapeutics Inc
9.80$
+3.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 5.43 | 15.58 | 2.02 | 17.22 | 9.50 | |
| – | – | 0.00 | 0.05 | 0.33 | 0.80 | 2.16 | 3.95 | 3.33 | 3.04 | 66.18 | 2.10 | 2.81 | 1.67 | |
| – | – | 0.00 | -0.05 | -0.33 | -0.80 | -2.16 | -3.95 | -3.33 | 5.43 | -50.60 | -0.07 | 14.41 | 7.83 | |
| 13.33 | 125.77 | 77.45 | 40.67 | 49.17 | 67.98 | 95.56 | 105.29 | 82.68 | 75.26 | 66.80 | 53.06 | 20.23 | 2.94 | |
| 3.41 | 97.22 | 63.73 | 16.45 | 21.52 | 33.76 | 39.75 | 38.78 | 21.77 | 21.03 | 16.70 | 12.02 | 5.33 | 2.06 | |
| 16.74 | 223.00 | 141.18 | 57.12 | 70.69 | 101.74 | 135.30 | 144.07 | 104.45 | 96.30 | 18.16 | 65.08 | 25.56 | 5.01 | |
| -4.40 | -223.00 | -141.18 | -57.12 | -70.69 | -101.74 | -135.30 | -144.07 | -104.45 | -90.87 | -68.76 | -65.15 | -11.14 | 2.82 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.74 | 3.64 | 2.59 | 0.09 | 1.25 | 0.62 | 0.30 | |
| -16.74 | -222.69 | -140.55 | -55.93 | -68.77 | -100.04 | -131.67 | -141.77 | -103.62 | -90.77 | -55.96 | -65.17 | -11.41 | 2.57 | |
| 0.07 | 4.40 | -0.13 | -0.01 | 0.01 | -0.01 | -0.03 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -168.15 | -2,270.86 | -140.42 | -55.92 | -68.78 | -100.03 | -131.64 | -141.78 | -103.63 | -90.78 | -55.96 | -65.18 | -11.41 | 2.57 | |
| -5.58 | -222.89 | -141.15 | -57.07 | -70.36 | -100.94 | -133.17 | -140.63 | -101.63 | -88.37 | -54.48 | -62.79 | -10.12 | 3.04 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.